1. Home
  2. GCO vs KALA Comparison

GCO vs KALA Comparison

Compare GCO & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genesco Inc.

GCO

Genesco Inc.

HOLD

Current Price

$27.81

Market Cap

286.0M

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.17

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCO
KALA
Founded
1924
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.0M
319.6M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
GCO
KALA
Price
$27.81
$0.17
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$33.00
$31.50
AVG Volume (30 Days)
212.0K
7.6M
Earning Date
03-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
171.84
41.50
EPS
1.25
N/A
Revenue
$2,606,898,000.00
N/A
Revenue This Year
$0.78
N/A
Revenue Next Year
$2.12
N/A
P/E Ratio
$22.38
N/A
Revenue Growth
13.71
N/A
52 Week Low
$16.19
$0.16
52 Week High
$38.95
$20.58

Technical Indicators

Market Signals
Indicator
GCO
KALA
Relative Strength Index (RSI) 54.80 24.66
Support Level $27.02 N/A
Resistance Level $29.79 $0.72
Average True Range (ATR) 1.30 0.03
MACD 0.41 -0.00
Stochastic Oscillator 77.18 2.17

Price Performance

Historical Comparison
GCO
KALA

About GCO Genesco Inc.

Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: